Prion Diseases: What Is the Neurotoxic Molecule?
暂无分享,去创建一个
[1] Terrance T. Kummer,et al. Mutant Prion Proteins Are Partially Retained in the Endoplasmic Reticulum* , 2001, The Journal of Biological Chemistry.
[2] R. Hegde,et al. Combinatorial Control of Prion Protein Biogenesis by the Signal Sequence and Transmembrane Domain* , 2001, The Journal of Biological Chemistry.
[3] J. Collinge,et al. Location and properties of metal-binding sites on the human prion protein , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[4] R. Glockshuber,et al. Electron paramagnetic resonance evidence for binding of Cu(2+) to the C-terminal domain of the murine prion protein. , 2001, Biophysical journal.
[5] B. Ghetti,et al. Prion proteins with different conformations accumulate in Gerstmann-Sträussler-Scheinker disease caused by A117V and F198S mutations. , 2001, The American journal of pathology.
[6] S. Hornemann,et al. Prion Protein Binds Copper within the Physiological Concentration Range* , 2001, The Journal of Biological Chemistry.
[7] W. Surewicz,et al. On the Mechanism of α-Helix to β-Sheet Transition in the Recombinant Prion Protein† , 2001 .
[8] S. Prusiner,et al. Shattuck lecture--neurodegenerative diseases and prions. , 2001, The New England journal of medicine.
[9] B. Dobberstein,et al. Prion Protein Contains a Second Endoplasmic Reticulum Targeting Signal Sequence Located at Its C Terminus* , 2001, The Journal of Biological Chemistry.
[10] N. Hooper,et al. Ablation of the metal ion-induced endocytosis of the prion protein by disease-associated mutation of the octarepeat region , 2001, Current Biology.
[11] R. S. Stewart,et al. A transmembrane form of the prion protein contains an uncleaved signal peptide and is retained in the endoplasmic Reticulum. , 2001, Molecular biology of the cell.
[12] B. Caughey,et al. Interactions between prion protein isoforms: the kiss of death? , 2001, Trends in biochemical sciences.
[13] A. Pestronk,et al. Primary Myopathy and Accumulation of PrPSc-Like Molecules in Peripheral Tissues of Transgenic Mice Expressing a Prion Protein Insertional Mutation , 2001, Neurobiology of Disease.
[14] C. Masters,et al. Sublethal Concentrations of Prion Peptide PrP106–126 or the Amyloid Beta Peptide of Alzheimer's Disease Activates Expression of Proapoptotic Markers in Primary Cortical Neurons , 2001, Neurobiology of Disease.
[15] F. Cohen,et al. A Protease-Resistant 61-Residue Prion Peptide Causes Neurodegeneration in Transgenic Mice , 2001, Molecular and Cellular Biology.
[16] H. Kretzschmar,et al. Prion Protein Affects Ca2+-Activated K+ Currents in Cerebellar Purkinje Cells , 2001, Neurobiology of Disease.
[17] A. Negro,et al. The Metabolism and Imaging in Live Cells of the Bovine Prion Protein in Its Native Form or Carrying Single Amino Acid Substitutions , 2001, Molecular and Cellular Neuroscience.
[18] B. Ghetti,et al. A 7-kDa Prion Protein (PrP) Fragment, an Integral Component of the PrP Region Required for Infectivity, Is the Major Amyloid Protein in Gerstmann-Sträussler-Scheinker Disease A117V* , 2001, The Journal of Biological Chemistry.
[19] A. Aguzzi,et al. Onset of ataxia and Purkinje cell loss in PrP null mice inversely correlated with Dpl level in brain , 2001, The EMBO journal.
[20] David R. Brown. Prion and prejudice: normal protein and the synapse , 2001, Trends in Neurosciences.
[21] A. Goldberg,et al. Cellular Defenses against Unfolded Proteins A Cell Biologist Thinks about Neurodegenerative Diseases , 2001, Neuron.
[22] S. Prusiner,et al. Structural Intermediates in the Putative Pathway from the Cellular Prion Protein to the Pathogenic Form , 2001, Biological chemistry.
[23] R. S. Stewart,et al. Most Pathogenic Mutations Do Not Alter the Membrane Topology of the Prion Protein* , 2001, The Journal of Biological Chemistry.
[24] F. Cohen,et al. Affinity-Tagged Miniprion Derivatives Spontaneously Adopt Protease-Resistant Conformations , 2000, Journal of Virology.
[25] Arunandan Kumar,et al. The Chaperone Protein BiP Binds to a Mutant Prion Protein and Mediates Its Degradation by the Proteasome* , 2000, The Journal of Biological Chemistry.
[26] A. Favier,et al. Prion infection impairs the cellular response to oxidative stress. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[27] F. Cohen,et al. Identification of the Cu2+ binding sites in the N-terminal domain of the prion protein by EPR and CD spectroscopy. , 2000, Biochemistry.
[28] H. True,et al. A yeast prion provides a mechanism for genetic variation and phenotypic diversity , 2000, Nature.
[29] P. Lantos,et al. Species-barrier-independent prion replication in apparently resistant species. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[30] M. Sy,et al. Prion disease: A loss of antioxidant function? , 2000, Biochemical and biophysical research communications.
[31] G. Forloni,et al. Apoptotic Cell Death and Impairment of L-Type Voltage-Sensitive Calcium Channel Activity in Rat Cerebellar Granule Cells Treated with the Prion Protein Fragment 106–126 , 2000, Neurobiology of Disease.
[32] H. Budka,et al. Evidence for Oxidative Stress in Experimental Prion Disease , 2000, Neurobiology of Disease.
[33] C. V. Mering,et al. Prion Protein Devoid of the Octapeptide Repeat Region Restores Susceptibility to Scrapie in PrP Knockout Mice , 2000, Neuron.
[34] M. Sy,et al. Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain. , 2000, The American journal of pathology.
[35] G. Forloni,et al. Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro. , 2000, Journal of molecular biology.
[36] D. Harris,et al. Nerve Growth Factor‐Induced Differentiation Does Not Alter the Biochemical Properties of a Mutant Prion Protein Expressed in PC12 Cells , 2000, Journal of neurochemistry.
[37] B. Ghetti,et al. Accumulation of protease-resistant prion protein (PrP) and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[38] R. Casareno,et al. Brain Copper Content and Cuproenzyme Activity Do Not Vary with Prion Protein Expression Level* , 2000, The Journal of Biological Chemistry.
[39] S. Warren,et al. Aberrant Protein Deposition and Neurological Disease* , 1999, The Journal of Biological Chemistry.
[40] S. Prusiner,et al. Transmissible and genetic prion diseases share a common pathway of neurodegeneration , 1999, Nature.
[41] A Helenius,et al. Setting the standards: quality control in the secretory pathway. , 1999, Science.
[42] F. Tagliavini,et al. Sporadic Creutzfeldt-Jakob disease: Co-occurrence of different types of PrPSc in the same brain , 1999, Neurology.
[43] I. Mcconnell,et al. A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy , 1999, The EMBO journal.
[44] K. Beyreuther,et al. Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity. , 1999, The American journal of pathology.
[45] A. Aguzzi,et al. Scrapie Pathogenesis in Subclinically Infected B-Cell-Deficient Mice , 1999, Journal of Virology.
[46] F E Cohen,et al. Protein misfolding and prion diseases. , 1999, Journal of molecular biology.
[47] Inyoul Y. Lee,et al. Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. , 1999, Journal of molecular biology.
[48] Fran Maher,et al. The Hydrophobic Core Sequence Modulates the Neurotoxic and Secondary Structure Properties of the Prion Peptide 106‐126 , 1999, Journal of neurochemistry.
[49] P. Lansbury,et al. Amyloid diseases: abnormal protein aggregation in neurodegeneration. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[50] S. Ferrari,et al. Proteasomal Degradation and N-terminal Protease Resistance of the Codon 145 Mutant Prion Protein* , 1999, The Journal of Biological Chemistry.
[51] John Collinge,et al. Variant Creutzfeldt-Jakob disease , 1999, The Lancet.
[52] D. Harris,et al. Prion proteins carrying pathogenic mutations are resistant to phospholipase cleavage of their glycolipid anchors. , 1999, Biochemistry.
[53] D. Perlmutter. Misfolded proteins in the endoplasmic reticulum. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[54] S. Prusiner,et al. Prion protein conformation in a patient with sporadic fatal insomnia. , 1999, The New England journal of medicine.
[55] R. Kaufman,et al. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. , 1999, Genes & development.
[56] F. Cohen,et al. Solution structure of Syrian hamster prion protein rPrP(90-231). , 1999, Biochemistry.
[57] J. Ironside,et al. Neuronal apoptosis in Creutzfeldt-Jakob disease. , 1999, Journal of neuropathology and experimental neurology.
[58] F. Tagliavini,et al. Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines. , 1999, Neuroreport.
[59] R. Glockshuber,et al. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. , 1999, Biochemistry.
[60] G. Landreth,et al. Identification of Microglial Signal Transduction Pathways Mediating a Neurotoxic Response to Amyloidogenic Fragments of β-Amyloid and Prion Proteins , 1999, The Journal of Neuroscience.
[61] R. Wickner,et al. Prions of Yeast and Fungi , 1999, The Journal of Biological Chemistry.
[62] D. Harris,et al. Copper Stimulates Endocytosis of the Prion Protein* , 1998, The Journal of Biological Chemistry.
[63] B. Ghetti,et al. Neurological Illness in Transgenic Mice Expressing a Prion Protein with an Insertional Mutation , 1998, Neuron.
[64] W. Surewicz,et al. Familial Mutations and the Thermodynamic Stability of the Recombinant Human Prion Protein* , 1998, The Journal of Biological Chemistry.
[65] F. Cohen,et al. Eight prion strains have PrPSc molecules with different conformations , 1998, Nature Medicine.
[66] K Wüthrich,et al. Prion protein NMR structure and familial human spongiform encephalopathies. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[67] A. Giese,et al. Role of Microglia in Neuronal Cell Death in Prion Disease , 1998, Brain pathology.
[68] H. Budka,et al. Neuronal Apoptosis in Fatal Familial Insomnia , 1998, Brain pathology.
[69] R. Hegde,et al. Regulation of protein topology by trans-acting factors at the endoplasmic reticulum. , 1998, Molecular cell.
[70] B. Chesebro,et al. Abnormal Properties of Prion Protein with Insertional Mutations in Different Cell Types* , 1998, The Journal of Biological Chemistry.
[71] Christian von Mering,et al. Expression of Amino-Terminally Truncated PrP in the Mouse Leading to Ataxia and Specific Cerebellar Lesions , 1998, Cell.
[72] B. Chesebro,et al. Scrapie infectivity found in resistant species , 1998, Nature.
[73] S. Prusiner,et al. A transmembrane form of the prion protein in neurodegenerative disease. , 1998, Science.
[74] B. Chesebro. BSE and Prions: Uncertainties About the Agent , 1998, Science.
[75] G. Forloni,et al. A Neurotoxic and Gliotrophic Fragment of the Prion Protein Increases Plasma Membrane Microviscosity , 1997, Neurobiology of Disease.
[76] Shu G. Chen,et al. Prion Protein Aggregation Reverted by Low Temperature in Transfected Cells Carrying a Prion Protein Gene Mutation* , 1997, The Journal of Biological Chemistry.
[77] S. Prusiner,et al. A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis , 1997, Journal of virology.
[78] F E Cohen,et al. A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. , 1997, Journal of molecular biology.
[79] H. Ushijima,et al. Effect of Flupirtine on Bcl-2 and Glutathione Level in Neuronal Cells Treatedin Vitrowith the Prion Protein Fragment (PrP106-126) , 1997, Experimental Neurology.
[80] A. Aguzzi,et al. Bovine spongiform encephalopathy and early onset variant Creutzfeldt—Jakob disease , 1997, Current Opinion in Neurobiology.
[81] K Wüthrich,et al. NMR characterization of the full‐length recombinant murine prion protein, mPrP(23–231) , 1997, FEBS letters.
[82] F. Cohen,et al. Heritable disorder resembling neuronal storage disease in mice expressing prion protein with deletion of an α-helix , 1997, Nature Medicine.
[83] J. Collinge,et al. Mossy fibre reorganization in the hippocampus of prion protein null mice , 1997, Brain Research.
[84] D. Harris,et al. Identification of Intermediate Steps in the Conversion of a Mutant Prion Protein to a Scrapie-like Form in Cultured Cells* , 1997, The Journal of Biological Chemistry.
[85] A. Rapak,et al. Retrograde transport of mutant ricin to the endoplasmic reticulum with subsequent translocation to cytosol. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[86] P. Lucassen,et al. PrP Deposition, Microglial Activation, and Neuronal Apoptosis in Murine Scrapie , 1997, Experimental Neurology.
[87] B. Chesebro,et al. Prion protein and the transmissible spongiform encephalopathies. , 1997, Trends in cell biology.
[88] J. Rossier,et al. Transmission of the BSE Agent to Mice in the Absence of Detectable Abnormal Prion Protein , 1997, Science.
[89] B. Kagan,et al. Channel Formation by a Neurotoxic Prion Protein Fragment* , 1997, The Journal of Biological Chemistry.
[90] S. Prusiner,et al. Evidence for the Conformation of the Pathologic Isoform of the Prion Protein Enciphering and Propagating Prion Diversity , 1996, Science.
[91] A. Aguzzi,et al. Normal host prion protein (PrPC) is required for scrapie spread within the central nervous system. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[92] S. Prusiner,et al. Decreased receptor-mediated calcium response in prion-infected cells correlates with decreased membrane fluidity and IP sub 3 release , 1996, Neurology.
[93] S. Prusiner,et al. Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice. , 1996, Genes & development.
[94] J Q Trojanowski,et al. Molecular basis of phenotypic variability in sporadc creudeldt‐jakob disease , 1996, Annals of neurology.
[95] D. Harris,et al. Two mutant prion proteins expressed in cultured cells acquire biochemical properties reminiscent of the scrapie isoform. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[96] R. Petersen,et al. Effect of the D178N Mutation and the Codon 129 Polymorphism on the Metabolism of the Prion Protein (*) , 1996, The Journal of Biological Chemistry.
[97] J. Collinge,et al. Hippocampal slices from prion protein null mice: disrupted Ca2+-activated K+ currents , 1996, Neuroscience Letters.
[98] P. Achermann,et al. Altered circadian activity rhythms and sleep in mice devoid of prion protein , 1996, Nature.
[99] T. Noda,et al. Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene , 1996, Nature.
[100] Bernhard Schmidt,et al. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment , 1996, Nature.
[101] A. Aguzzi,et al. Prion protein (PrP) with amino‐proximal deletions restoring susceptibility of PrP knockout mice to scrapie. , 1996, The EMBO journal.
[102] M. Hoque,et al. Experimental transmission of Creutzfeldt-Jakob disease and related diseases to rodents , 1996, Neurology.
[103] A. Aguzzi,et al. Normal host prion protein necessary for scrapie-induced neurotoxicity , 1996, Nature.
[104] D. Harris,et al. Mutant and Infectious Prion Proteins Display Common Biochemical Properties in Cultured Cells (*) , 1996, The Journal of Biological Chemistry.
[105] H. Kretzschmar,et al. Prion disease associated with a novel nine octapeptide repeat insertion in the PRNP gene. , 1995, Brain research. Molecular brain research.
[106] D. Harris,et al. A Mutant Prion Protein Displays an Aberrant Membrane Association When Expressed in Cultured Cells (*) , 1995, The Journal of Biological Chemistry.
[107] R. Castellani,et al. Regional distribution of protease‐resistant prion protein in fatal familial insomnia , 1995, Annals of neurology.
[108] A. Giese,et al. Neuronal Cell Death in Scrapie‐Infected Mice Is Due to Apoptosis , 1995, Brain pathology.
[109] N. MacLeod,et al. PrP gene dosage and long term potentiation. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.
[110] I. Mcconnell,et al. PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. , 1994, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.
[111] B. Ghetti,et al. Amyloid fibrils in Gerstmann-Sträussler-Scheinker disease (Indiana and Swedish Kindreds) express only PrP peptides encoded by the mutant allele , 1994, Cell.
[112] A. Aguzzi,et al. High Prion and PrPSc Levels but Delayed Onset of Disease in Scrapie-Inoculated Mice Heterozygous for a Disrupted PrP Gene , 1994, Molecular medicine.
[113] H. Kretzschmar,et al. Mouse cortical cells lacking cellular PrP survive in culture with a neurotoxic PrP fragment , 1994, Neuroreport.
[114] S. Prusiner,et al. Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[115] G. Forloni,et al. A Neurotoxic Prion Protein Fragment Induces Rat Astroglial Proliferation and Hypertrophy , 1994, The European journal of neuroscience.
[116] J. Ironside,et al. Prion protein immunocytochemistry: reliable protocols for the investigation of Creutzfeldt–Jakob disease , 1994, Neuropathology and applied neurobiology.
[117] M. Palmer,et al. Prion protein is necessary for normal synaptic function , 1994, Nature.
[118] S. Prusiner,et al. Determinants of carboxyl-terminal domain translocation during prion protein biogenesis. , 1994, The Journal of biological chemistry.
[119] M. Jeffrey,et al. Murine scrapie-infected neurons in vivo release excess prion protein into the extracellular space , 1994, Neuroscience Letters.
[120] P. Brown,et al. Human spongiform encephalopathy: The national institutes of health series of 300 cases of experimentally transmitted disease , 1994, Annals of neurology.
[121] R J Fletterick,et al. Structural clues to prion replication. , 1994, Science.
[122] G. Forloni,et al. Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. , 1994, The Journal of biological chemistry.
[123] S. Prusiner,et al. Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins , 1994, Cell.
[124] R J Fletterick,et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[125] S. Prusiner,et al. Scrapie prions alter receptor‐mediated calcium responses in cultured cells , 1993, Neurology.
[126] G. Forloni,et al. Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. , 1993, Biochemical and biophysical research communications.
[127] H. Ushijima,et al. Cytoprotective effect of NMDA receptor antagonists on prion protein (PrionSc)-induced toxicity in rat cortical cell cultures. , 1993, European journal of pharmacology.
[128] A. Aguzzi,et al. Mice devoid of PrP are resistant to scrapie , 1993, Cell.
[129] P. Lansbury,et al. Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.
[130] A. Harding,et al. Dementia associated with a 216 base pair insertion in the prion protein gene. Clinical and neuropathological features. , 1993, Brain : a journal of neurology.
[131] G. Forloni,et al. Neurotoxicity of a prion protein fragment , 1993, Nature.
[132] L. Hood,et al. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. , 1993, Biochemistry.
[133] S. Prusiner,et al. Evidence for synthesis of scrapie prion proteins in the endocytic pathway. , 1992, The Journal of biological chemistry.
[134] P. Brown,et al. "Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease , 1992, The Lancet.
[135] S. Prusiner,et al. Replication of distinct scrapie prion isolates is region specific in brains of transgenic mice and hamsters. , 1992, Genes & development.
[136] S. Prusiner,et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein , 1992, Nature.
[137] T. Crow,et al. A dementing illness associated with a novel insertion in the prion protein gene. , 1992, Brain research. Molecular brain research.
[138] G. J. Raymond,et al. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. , 1991, The Journal of biological chemistry.
[139] S. Prusiner,et al. Proteinase‐resistant prion protein accumulation in Syrian hamster brain correlates with regional pathology and scrapie infectivity , 1991, Neurology.
[140] B. Caughey,et al. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. , 1991, Biochemistry.
[141] H. Deng,et al. Alterations in neurotransmitter-related enzyme activity in scrapie-infected PC12 cells. , 1991, The Journal of general virology.
[142] H. Fraser,et al. The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. , 1991, The Journal of general virology.
[143] S. Prusiner,et al. Spontaneous neurodegeneration in transgenic mice with mutant prion protein , 1990, Science.
[144] Stephen J. DeArmond,et al. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication , 1990, Cell.
[145] S. Prusiner,et al. Differential release of cellular and scrapie prion proteins from cellular membranes by phosphatidylinositol-specific phospholipase C. , 1990, Biochemistry.
[146] S. Prusiner,et al. Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells , 1990, The Journal of cell biology.
[147] S. Prusiner,et al. Unusual topogenic sequence directs prion protein biogenesis. , 1990, Science.
[148] S. Prusiner,et al. Non-hydrophobic extracytoplasmic determinant of stop transfer in the prion protein , 1990, Nature.
[149] Stephen J. DeArmond,et al. Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques , 1989, Cell.
[150] P. McBride,et al. Precise targeting of the pathology of the sialoglycoprotein, PrP, and vacuolar degeneration in mouse scrapie , 1989, Neuroscience Letters.
[151] B. Chesebro,et al. Analyses of frequency of infection, specific infectivity, and prion protein biosynthesis in scrapie-infected neuroblastoma cell clones , 1988, Journal of virology.
[152] S. Prusiner,et al. Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins , 1988, Journal of virology.
[153] S. Prusiner,et al. Distinct prion proteins in short and long scrapie incubation period mice , 1987, Cell.
[154] S. Prusiner,et al. Changes in the localization of brain prion proteins during scrapie infection , 1987, Neurology.
[155] S. Prusiner,et al. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene , 1986, Cell.
[156] Ruedi Aebersold,et al. A cellular gene encodes scrapie PrP 27-30 protein , 1985, Cell.
[157] L. Hood,et al. Purification and structural studies of a major scrapie prion protein , 1984, Cell.
[158] S. Prusiner. Novel proteinaceous infectious particles cause scrapie. , 1982, Science.
[159] J. Griffith,et al. Nature of the Scrapie Agent: Self-replication and Scrapie , 1967, Nature.
[160] TIKVAH ALPER,et al. Does the Agent of Scrapie Replicate without Nucleic Acid ? , 1967, Nature.
[161] D. Gajdusek,et al. Degenerative disease of the central nervous system in New Guinea; the endemic occurrence of kuru in the native population. , 1957, The New England journal of medicine.
[162] A. Chong,et al. Onset of accumulation of PrPres in murine ME7 scrapie in relation to pathological and PrP immunohistochemical changes. , 2001, Journal of comparative pathology.
[163] J. Collinge. Prion diseases of humans and animals: their causes and molecular basis. , 2001, Annual review of neuroscience.
[164] D. Riesner,et al. Neurotoxicity but not infectivity of prion proteins can be induced reversibly in vitro. , 2000, Archives of virology. Supplementum.
[165] S. DeArmond,et al. 14 Neuropathology of Prion Diseases , 1999 .
[166] J. Bonifacino,et al. Ubiquitin and the control of protein fate in the secretory and endocytic pathways. , 1998, Annual review of cell and developmental biology.
[167] Michael Wall,et al. Friendly Fire , 1998 .
[168] F E Cohen,et al. Pathologic conformations of prion proteins. , 1998, Annual review of biochemistry.
[169] P. Walter,et al. Intracellular signaling from the endoplasmic reticulum to the nucleus. , 1998, Annual review of cell and developmental biology.
[170] R. Carp,et al. Brain regional distribution of prion protein PrP27-30 in mice stereotaxically microinjected with different strains of scrapie. , 1993, The Journal of infectious diseases.
[171] A. Helenius,et al. Protein oligomerization in the endoplasmic reticulum. , 1989, Annual review of cell biology.